Group One Trading, L.P. Aslan Pharmaceuticals LTD Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.36 - $24.24 $3,406 - $229,358	-9,462 Reduced 65.56%	4,970 $1,000
Q3 2022 Nov 09, 2022	SELL	$0.42 - $24.68 $2,604 - $153,016	-6,200 Reduced 30.05%	14,432 $9,000
Q2 2022 Aug 11, 2022	BUY	$0.36 - $0.9 $540 - $1,350	1,500 Added 7.84%	20,632 $10,000
Q1 2022 May 12, 2022	SELL	$0.74 - $1.22 $540 - $890	-730 Reduced 3.68%	19,132 $17,000
Q4 2021 Feb 11, 2022	BUY	$1.11 - $1.86 $3,536 - $5,925	3,186 Added 19.11%	19,862 $22,000
Q3 2021 Nov 12, 2021	BUY	$1.78 - $3.41 $29,683 - $56,865	16,676 New	16,676 $30,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.